أعرض في EDS

829 The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘iressa’, ZD-1839) and the protein prenyltransferase inhibitor M365408 as potential therapeutics in bladder cancer

التفاصيل البيبلوغرافية
العنوان:	829 The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘iressa’, ZD-1839) and the protein prenyltransferase inhibitor M365408 as potential therapeutics in bladder cancer
المؤلفون:	B.R. Davies, J.L. Dominguez-escrig, John D. Kelly
المصدر:	European Urology Supplements. 3:210
بيانات النشر:	Elsevier BV, 2004.
سنة النشر:	2004
مصطلحات موضوعية:	biology, business.industry, Urology, Receptor tyrosine kinase, Gefitinib, Growth factor receptor, ROR1, biology.protein, Cancer research, Medicine, Growth factor receptor inhibitor, business, Tyrosine kinase, Platelet-derived growth factor receptor, medicine.drug, Proto-oncogene tyrosine-protein kinase Src
تدمد:	1569-9056
DOI:	10.1016/s1569-9056(04)90821-4
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::3cea6506d847c331d32a0250c1bbdad2 https://doi.org/10.1016/s1569-9056(04)90821-4
Rights:	CLOSED
رقم الانضمام:	edsair.doi...........3cea6506d847c331d32a0250c1bbdad2
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	15699056
DOI:	10.1016/s1569-9056(04)90821-4